Sign in
POSTER: MDS-605 Disease Modifying Activity of Imetelstat in Patients With Heavily Transfused Non-Del(5q) Lower-Risk Myelodysplastic Syndromes Relapsed/ Refractory/Ineligible for Erythropoiesis-Stimulating Agents in IMerge Phase 3
Journal article   Peer reviewed

POSTER: MDS-605 Disease Modifying Activity of Imetelstat in Patients With Heavily Transfused Non-Del(5q) Lower-Risk Myelodysplastic Syndromes Relapsed/ Refractory/Ineligible for Erythropoiesis-Stimulating Agents in IMerge Phase 3

Valeria Santini, Uwe Platzbecker, Pierre Fenaux, Mikkael Sekeres, Michael Savona, Yazan Madanat, Maria Díez-Campelo, David Valcárcel-Ferreiras, Thomas Illmer, Anna Jonášová, …
Clinical lymphoma, myeloma and leukemia, Vol.23, pp.S186-S186
2023-09

Metrics

1 Record Views

Details